Lineage Cell Therapeutics, Inc.
LCTX · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Bradsher Neal C: Form 4
Insider disclosure · Filed · Report period 01 Jul 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- LCTX · 53566P109 - Common Stock
Company details and SEC sources
CIK 0000876343 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- LCTX on NYSE
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 2173 Salk Avenue, Suite 200, Carlsbad, CA, 92008
- Incorporated in
- CA
- Fiscal year end
- 31 December
- Former names on EDGAR
- BIOTIME INC (to 08 Aug 2019)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields